Gemphire Therapeutics Inc. 4
4 · Gemphire Therapeutics Inc. · Filed Feb 3, 2017
Insider Transaction Report
Form 4
KOUSKY KENNETH W
Director
Transactions
- Other
Common Stock
2017-02-01−110,428→ 6,463 total(indirect: By LLC) - Other
Common Stock
2017-02-01−101,406→ 4,472 total(indirect: By LLC)
Holdings
- 1,000
Common Stock
Footnotes (4)
- [F1]The transaction on this line represents a pro rata distribution by BWA Gemphire Investment Group, LLC ("BWA") to its members without consideration.
- [F2]Mr. Kousky, as the Manager of BWA, beneficially owns the reported securities indirectly.
- [F3]The transaction on this line represents a pro rata distribution by BWA Gemphire Investment Group II, LLC ("BWA II") to its members without consideration.
- [F4]Mr. Kousky, as the Manager of BWA II, beneficially owns the reported securities indirectly.